Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
about
Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.Phenotypic and functional heterogeneity of bovine blood monocytesMonocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disordersDifferentiation Kinetics of Blood Monocytes and Dendritic Cells in Macaques: Insights to Understanding Human Myeloid Cell Development.CD14brightCD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis.Clinical significance of monocyte heterogeneity.Aggressive periodontitis: A clinico-hematological appraisal.Toward a refined definition of monocyte subsets.Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.In-Depth Proteomic Characterization of Classical and Non-Classical Monocyte Subsets.Heterogeneity of Bovine Peripheral Blood Monocytes.The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.HIV-1 does not alter in vitro and in vivo IL-10 production by human monocytes and macrophages.The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung.
P2860
Q33820660-01635D1E-5B50-487D-A9FB-594B6D6C0632Q34590873-FAB5FBFB-87E3-44EB-8A64-EC22D4A97D87Q34870353-08331533-F1D2-419E-A1C0-C11661312270Q34964110-79408D62-3EA3-4646-BB55-534C914A273BQ35154529-04EF4D97-42E0-47BE-ADE5-AEA31B406386Q35931615-BDCDA97C-6685-4E46-A89F-DEA3CF6516A6Q37635350-0E4CC8DF-2FE7-4A9F-BEB7-6DC67C833FD8Q38411099-D60891B0-6E64-4233-9825-DF4F277467F6Q39945303-050EE0A4-BC47-4DA2-88FF-AD6D781B1225Q43143550-6C0BBD18-249B-442E-B5CA-913954F171FCQ47901392-1FB7E879-6CA8-457F-8CE4-62096571ACB2Q48104334-F56D1791-0029-427A-936F-D04C931E3F79Q50130264-B075A076-6138-4D3E-9503-C9197636E36CQ50131761-265759E6-E6D6-40D4-89C6-E4D49BC80D7CQ53919959-7C3D1C37-D6E1-4D62-AC2B-0C4FCCB75295Q55046775-336C7735-E898-4D67-BA4F-630D5A425582
P2860
Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@ast
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@en
type
label
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@ast
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@en
prefLabel
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@ast
Phase I trial of recombinant m ...... cytosis, and clinical effects.
@en
P2093
P1433
P1476
Phase I trial of recombinant m ...... ocytosis, and clinical effects
@en
P2093
Alpaugh RK
Catalano RB
Dovnarsky M
P304
P407
P577
1994-08-01T00:00:00Z